Randall C. Schatzman, President and CEO at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 20,000 shares at $32.48 ($650K) on 2016-09-01, disclosed to the SEC on 2016-09-06.
Open-market sale of $650k ALDR by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.48 | 10,000 | $325K | 50.0% |
| 2 | $32.48 | 10,000 | $325K | 50.0% |
| Total | $32.48 avg | 20,000 | $650K | 100% |
| Filing → |
| ALDR | SELL | 2016-11-09 | $252K | — | Filing → |
| ALDR | SELL | 2016-10-05 | $424K | — | Filing → |
| ALDR | SELL | 2016-08-03 | $622K | — | Filing → |